A few years ago, if someone told you women were asking their doctors for testosterone during menopause, it would have sounded… fringe. Like a weird biohacker corner of the internet. Something your gym bro cousin would bring up at Thanksgiving.

Now it is showing up in regular conversations. In women’s health clinics. In peri menopause forums. On TikTok. In private group chats where someone finally says what everyone else has been thinking.

I feel flat. I have no spark. I do not recognize my body. I am tired all the time. Sex feels… distant. Like it belongs to another version of me.

And then someone mentions testosterone.

Not as a bodybuilding thing. Not as a transition thing. As a menopause thing. As a maybe this is the missing piece thing.

But here is where it gets messy. There is real evidence for some uses of testosterone in midlife women. And there is also a lot of hype, overselling, and sloppy prescribing. There are clinics that talk like testosterone is the answer to everything. Weight loss. Brain fog. Anxiety. Motivation. Marriage problems. Your messy house. Your lack of ambition. Your aging face. No.

So let’s slow down and do the unglamorous part. What is testosterone doing in women’s bodies. What changes in menopause. What the best evidence actually supports. What the risks are. And why so many women are still seeking it anyway.

This is not medical advice. It is a map. You still need a clinician who knows what they are doing. And that last part matters more than people think.

First, yes, women already have testosterone

Testosterone is usually introduced as the male hormone. Which is technically true in the sense that men have much higher levels.

But women produce testosterone too. Mostly from the ovaries and the adrenal glands. And some comes from conversion of other hormones in peripheral tissues. Fat, skin, other places. The point is, it is not some foreign substance to a female body.

Testosterone in women is involved in:

• sexual desire and arousal
• sexual responsiveness and orgasm
• energy, vitality, motivation (this one is trickier, more on that later)
• maintaining lean mass and muscle strength over time
• bone health (again, part of a bigger system)
• mood and general well being, at least indirectly

And not all of this is well pinned down with clean studies. But the sexual function link, that one is the clearest.

What happens to testosterone during peri menopause and menopause

Here is where the popular narrative sometimes gets a little too simple.

Most people know estrogen drops in menopause. Progesterone drops too. But testosterone does not always fall off a cliff the same way estrogen does. Testosterone levels in women decline gradually with age, and the transition is not identical for everyone.

That said, some women do experience a meaningful decline, especially after surgical menopause (ovaries removed). And even without surgery, the combined changes in estrogen, progesterone, SHBG (sex hormone binding globulin), and overall endocrine signaling can shift how testosterone is available to tissues.

A quick but important concept: free testosterone versus total testosterone.

• Total testosterone is everything in the bloodstream.
• Free testosterone is the portion not bound tightly to proteins, and it is more biologically active.
• SHBG binds testosterone. If SHBG is high, free testosterone can be low even if total looks “normal.”

Estrogen therapy can raise SHBG (especially oral estrogen), which can lower free testosterone. That is one reason some women on estrogen still feel like something is missing, particularly in libido.

So you end up with a real world scenario like this:

A woman in her late 40s or 50s starts menopause hormone therapy. Hot flashes improve. Sleep improves. Mood stabilizes a bit. Vaginal dryness improves with local estrogen. And yet.

Sex drive is still gone. Or orgasms are weaker. Or the mental “interest” switch is just off.

That is where testosterone gets discussed most.

The one use where the evidence is actually strong: low sexual desire

If you only remember one part of this article, make it this:

The best supported medical use of testosterone therapy for women in menopause is for hypoactive sexual desire disorder (HSDD).

HSDD is not just “I’m busy and tired.” It is a persistent lack of sexual desire that causes personal distress. That distress part matters. Some women have low desire and feel totally fine. That is not a disorder.

Multiple randomized controlled trials and meta analyses have found that testosterone therapy can improve sexual desire and related measures in postmenopausal women with HSDD. It can also improve sexual satisfaction and reduce sexual distress.

Not in a dramatic movie montage way. More like:

I think about sex again. I initiate sometimes. I feel more responsive. It is not a chore. I feel like myself.

That kind of shift.

What about women in peri menopause

Data exists for peri menopausal women too, but the clearest regulatory and guideline language tends to focus on postmenopause. Still, clinically, many providers evaluate peri menopausal women with distressing low desire similarly, particularly when other factors are addressed and estrogen status is optimized.

The big caveat is this. Libido is complicated. Relationship context matters. Mental health matters. Medications matter. Pain matters. Sleep matters. Vaginal dryness matters. If sex hurts, desire tends to leave the building.

So testosterone is not step one. It is not even step two for many women. But for some, it is the missing lever.

Interestingly, recent studies have shown that testosterone therapy may also be beneficial for certain cases of female sexual dysfunction, which expands the potential applications of this treatment beyond just HSDD in postmenopausal women.

Why the surge now A few cultural and medical reasons

This trend did not come out of nowhere. A bunch of things collided.

1. Women are finally talking openly about menopause

For decades, menopause was treated like a punchline or a private shame. Now women are sharing symptoms publicly and comparing notes. That creates demand. And also creates pressure on the medical system to offer more than “that is just aging.”

2. Many women feel underserved by standard care

A lot of women still struggle to access competent menopause care. They are dismissed. Misdiagnosed. Put on antidepressants without a real discussion. Or told they are too young for perimenopause when they are 43 and clearly having symptoms.

When standard care feels like a dead end, people seek alternatives. Sometimes that is good. Sometimes it leads to clinics that oversell.

3. Libido and identity are tied together for many women

This part is emotional, and it matters.

For some women, losing sexual desire is not just about sex. It feels like losing a part of themselves. Their confidence. Their sense of aliveness. Their connection to their partner. Their physical ease in their own body.

So when they hear testosterone might help, they pay attention.

4. Telehealth and private clinics made access easier

In some countries, there is no FDA approved testosterone product for women, even though it is used off label. That creates a strange situation where women either cannot access it at all, or they can access it through specialized clinicians and compounding pharmacies.

Telehealth menopause clinics have stepped into that gap. Some do it carefully. Some are… aggressive.

The problem: testosterone is being marketed as a cure for everything

This is where you need to be skeptical.

In evidence based medicine, testosterone for women has a primary supported indication: HSDD in postmenopausal women.

But in the real world, you will hear claims like:

• it melts belly fat
• it fixes brain fog
• it reverses aging
• it builds muscle effortlessly
• it cures depression
• it restores ambition and drive
• it improves cognition long term
• it prevents Alzheimer’s
• it fixes your thyroid
• it fixes your metabolism

Some of those have kernels of plausibility. Testosterone has anabolic effects. It interacts with neurotransmitter systems. It might influence mood and energy in some women. But the quality of evidence is not the same as it is for sexual desire. And the outcomes are harder to measure. More placebo prone. More confounded.

Also, midlife is when a lot of things happen at once. Sleep disruption. Stress. Caring for parents. Teen kids. Work pressure. Body composition changes. Loss. Anxiety. You can feel flat for a dozen reasons. Testosterone is not a universal explanation.

So what does the evidence say beyond libido

Let’s separate “possible,” “unclear,” and “not supported.”

Energy, mood, motivation

Some women report better energy, improved mood, more assertiveness, more drive. That is a common anecdotal theme.

The research is mixed. Trials designed for sexual function sometimes show modest improvements in well being measures, but it is not consistent. And again, placebo effects in hormone studies can be strong because expectations are strong.

If someone has severe fatigue, you also have to rule out:

• iron deficiency
• thyroid disease
• sleep apnea
• depression or anxiety
• chronic stress and burnout
• medication effects (SSRIs, etc)
• low estrogen itself, because estrogen loss alone can wreck sleep and mood

So yes, testosterone might help some women feel more vitality. But it is not the slam dunk indication.

Muscle, strength, body composition

Testosterone is anabolic. That is true. But the doses used for women’s sexual health are much lower than bodybuilding levels.

Some studies suggest small improvements in lean mass or muscle performance, but results vary, and the clinical significance can be modest. Also, the best muscle preserving intervention in menopause is still boring:

Protein. Progressive strength training. Adequate sleep. Enough calories and not chronic dieting. Estrogen therapy when appropriate, because estrogen also matters for muscle function.

If a clinic promises testosterone will reshape your body without effort, run.

Bone density

Androgen pathways can influence bone, but estrogen is the primary player in menopause related bone loss. Testosterone is not a first line bone therapy for postmenopausal women. If bone health is the main concern, you would look at DEXA scans, calcium and vitamin D adequacy, strength training, estrogen therapy when appropriate, or osteoporosis medications.

Cognition and brain fog

Brain fog is real. Anyone who has been through perimenopause knows it. But the mechanism is complex, and it is not just testosterone.

Evidence that testosterone improves cognition in menopausal women is limited and not definitive. Some studies in other contexts suggest androgens can influence certain cognitive domains, but translating that into “testosterone fixes menopause brain fog” is a leap.

If brain fog is severe, also consider sleep. Hot flashes. Anxiety. ADHD traits becoming obvious in midlife. Iron deficiency. Medication side effects. Thyroid. A lot of people are walking around half asleep for years.

Safety and risks what we actually know

This is the part that gets glossed over in social media content. Because it is less fun.

Testosterone therapy at doses intended to bring levels into the normal premenopausal female range is generally considered safe in the short term in studied populations. However, “short term” matters. Many trials are 6 to 24 months. Long term safety data is more limited, especially for cardiovascular outcomes and breast cancer risk at various exposures.

Known and potential side effects include:

Androgenic side effects

These are the classic ones, especially if dose is too high.

• acne or oily skin
• increased facial or body hair growth (hirsutism)
• scalp hair thinning or androgenic alopecia in susceptible women
• voice deepening (rare at physiological dosing but can be irreversible if it occurs)
• clitoral enlargement (uncommon, usually with excessive dosing)

These are not just cosmetic. Hair loss and voice change can be deeply distressing. This is why dosing and monitoring matter.

Lipids and cardiovascular risk

Oral testosterone can adversely affect lipids. Transdermal forms are generally preferred to avoid first pass liver metabolism and potentially reduce lipid impacts.

But even with transdermal, clinicians should consider baseline cardiovascular risk, metabolic health, and monitor lipids when appropriate. The evidence does not clearly show major cardiovascular harm at physiological dosing, but data is not perfect. For more detailed information on this aspect, you can refer to a comprehensive study published in the Journal of Obstetrics and Gynaecology Canada.

Liver

Again, oral formulations are more of a concern. But routine clinical monitoring is part of careful prescribing. It’s important to note that while testosterone therapy has its risks, understanding these risks and managing them effectively can lead to successful outcomes. For further insights into the long-term effects of testosterone therapy, a thorough review available on PubMed Central provides valuable information.

Mood changes

Some women feel more confident and steady. Others can feel irritable, edgy, or more reactive if dosing is too high. If someone has a history of mood disorders, this needs thoughtful oversight.

Breast and endometrial concerns

Current evidence does not show a clear increased breast cancer risk with physiological testosterone therapy for the HSDD indication in the short term, but long term outcomes remain an area of ongoing study.

Testosterone itself does not stimulate the endometrium the way unopposed estrogen can, but women on combined regimens still need standard gynecologic surveillance. And if bleeding happens after menopause, that is always a medical evaluation situation, regardless of which hormones are involved.

The big clinical issue: dosing and the Wild West problem

In many places, there is no testosterone product officially approved for women. That means clinicians often prescribe:

• lower doses of products designed for men, carefully adjusted
• compounded testosterone creams or gels
• occasionally other delivery methods, depending on region and practice

This opens the door to a major problem.

Some women end up on doses that push testosterone well above the female physiological range. Sometimes dramatically above. They might feel great at first. More energy, more libido, more everything. But they also rack up side effects. And the long term risk profile becomes even less certain.

Pellets are a hot spot here

Testosterone pellets, implanted under the skin, are popular in some private clinics. They deliver hormone over months.

Some women love them. Some have issues. The main concerns clinicians raise are:

• dosing is harder to titrate
• if the dose is too high, you cannot just stop it easily
• levels can become supraphysiologic
• monitoring and standardization vary

This does not mean pellets are inherently evil. It means they require caution, an experienced prescriber, and honest conversations about tradeoffs.

How testosterone should be prescribed, according to most expert guidance

Different medical societies have their own statements, but many converge on similar principles. In plain language, careful testosterone therapy for menopausal women tends to look like this:

• The main indication is distressing low sexual desire (HSDD), after a proper evaluation.
• Use the lowest dose that improves symptoms while keeping levels in the normal premenopausal female range.
• Prefer transdermal delivery when possible.
• Avoid supraphysiologic dosing.
• Monitor symptoms and side effects closely.
• Check testosterone levels to avoid overshooting, usually total testosterone, sometimes free testosterone, and SHBG.
• Reassess whether it is helping. If it is not helping within a reasonable time frame, stop.

Also, clinicians should evaluate other contributors to low desire:

• relationship factors, stress, resentment, lack of privacy, mismatched desire
• depression and anxiety
• medications that lower libido (SSRIs are a big one)
• vaginal dryness or pain (genitourinary syndrome of menopause)
• inadequate estrogen treatment in symptomatic women
• sleep and fatigue

Testosterone is often a piece of a bigger plan, not the plan.

What a good evaluation for low libido actually looks like

This matters because a lot of women get offered testosterone without anyone really unpacking what is happening.

A decent evaluation includes questions like:

• Did desire drop suddenly or gradually
• Is it situational or across all contexts
• Is arousal possible once you start, or is it dead throughout
• Is sex painful
• Are orgasms different
• Are you on antidepressants, birth control, other meds
• How is sleep
• How is the relationship, honestly
• Are there mood symptoms
• What menopause symptoms are present, and are they treated

Sometimes the answer is local vaginal estrogen plus pelvic floor therapy. Sometimes it is adjusting an antidepressant. Sometimes it is couples therapy. Sometimes it is estrogen therapy. Sometimes it is all of it. And sometimes, yes, it is testosterone.

What “normal testosterone levels” means for women and why labs can confuse people

Women’s testosterone levels are much lower than men’s, and lab reference ranges can be weird. Different assays vary. Some standard tests are not very accurate at low female levels. That is a known problem.

Also, symptoms do not map perfectly to a number. A woman can have “normal” total testosterone and still have distressing low desire. Another woman can have low levels and feel fine.

So most good clinicians treat testosterone therapy as symptom guided within safe physiological limits, not as a chase the number game.

Still, labs are useful to prevent excessive dosing and to confirm baseline status.

The “I want testosterone for weight loss” question

This comes up constantly. And I get it. Menopause weight changes feel unfair. You can eat the same, exercise the same, and your body seems to reorganize itself overnight. More central fat. Less muscle. Clothes fitting differently. It can feel like betrayal.

But testosterone is not a weight loss drug.

If testosterone improves libido and energy, some women may move more, train harder, feel better, and body composition might shift slightly. But that is indirect. If someone is offered testosterone as the primary solution for weight loss, that is not evidence based care.

If weight is the main concern, evidence based options include:

• strength training and higher protein intake, consistently
• sleep optimization and treating hot flashes
• reviewing medications that promote weight gain
• evaluating insulin resistance, lipids, blood pressure
• considering anti obesity medications if appropriate (this is a medical decision)
• considering estrogen therapy when indicated, which can help with fat distribution and metabolic changes for some women

Again, boring. Effective. Not sexy on social media.

Why some women feel amazing on testosterone even if they were not “low”

This is the tricky psychological and biological part.

If you increase testosterone above where someone naturally sits, they may feel a noticeable change. More drive. More confidence. More libido. More edge. That does not automatically mean it is the right long term move.

It is similar to how someone without ADHD can take a stimulant and feel focused. The feeling is real. But it does not mean the person had a deficiency that needed correcting. And it does not mean the risk profile is acceptable over time.

This is why the goal in medical testosterone therapy for women is typically to keep levels within the normal female range, not to create a mini performance enhancement cycle.

Some clinics quietly do the latter. Patients often do not realize it until side effects show up. Or until they get labs back and their numbers are way outside range.

Practical red flags if you are considering testosterone

If you are a woman exploring testosterone for menopause symptoms, these are the things that should make you pause.

• You are promised it will fix everything.
• No one asks about pain with sex, relationship context, meds, mood, sleep.
• No one checks baseline labs.
• Dosing is not discussed in terms of female physiological ranges.
• You are pushed toward pellets with no real talk about titration limits.
• Side effects like hair loss and voice changes are brushed off.
• You are given a dose that makes your labs comparable to male levels.
• Follow up is vague, like “see you in six months.”

On the flip side, green flags look like:

• thoughtful evaluation, not a script
• clear primary goal (usually sexual desire)
• realistic expectations
• conservative dosing
• planned follow ups and lab monitoring
• willingness to stop if it is not helping

What about DHEA is that the same thing

DHEA is a precursor hormone produced by the adrenal glands. It can convert into androgens and estrogens in tissues. Some women use oral DHEA supplements. There is also vaginal DHEA (prasterone) used for genitourinary symptoms in some regions.

Oral DHEA for libido has mixed evidence. Some women swear by it. The data is not as strong as testosterone for HSDD. And because supplements vary in quality, dosing can be inconsistent.

Vaginal DHEA is a different category, more localized effects, typically for vaginal dryness and pain, not a systemic libido boost.

If you are considering DHEA, it is still worth discussing with a clinician, especially if you have hormone sensitive conditions.

Where this all lands the honest summary

Women are turning to testosterone for menopause because a lot of them feel like something important went missing. Not just hot flashes. Not just periods ending. Something about desire, vitality, embodiment. And many are not getting help from the standard menu.

The evidence supports testosterone therapy most strongly for one thing:

postmenopausal women with distressing low sexual desire (HSDD).

Beyond that, benefits for mood, energy, body composition, and cognition are possible for some women but not as well established. And the risk of overtreatment is real, especially with poorly monitored dosing or products that push levels too high.

So the “right” approach is not testosterone for everyone. And it is not testosterone never. It is careful, targeted use, with clear goals and tight monitoring. And with the humility to admit that sometimes what a woman needs is estrogen. Or sleep. Or treatment for pain. Or a medication change. Or help with depression. Or a different conversation entirely.

If you are curious about testosterone, the best next step is not ordering something online or copying a stranger’s protocol. It is finding a clinician who actually understands menopause care and who is willing to treat your symptoms seriously, without turning hormones into a miracle brand.

Because this is the real promise here. Not eternal youth. Not superhero energy. Just feeling like yourself again. And doing it safely.

FAQs (Frequently Asked Questions)

Do women produce testosterone, and what role does it play in their bodies?

Yes, women naturally produce testosterone primarily from the ovaries and adrenal glands, as well as from conversion in peripheral tissues like fat and skin. In women, testosterone is involved in sexual desire and arousal, sexual responsiveness and orgasm, energy and motivation, maintaining lean muscle mass and strength, bone health, and indirectly supports mood and general well-being.

How does testosterone change during peri menopause and menopause?

Testosterone levels in women decline gradually with age rather than dropping sharply like estrogen. Some women experience a meaningful decline especially after surgical menopause (ovary removal). Changes in hormones such as estrogen, progesterone, and sex hormone binding globulin (SHBG) during menopause can affect the availability of free (active) testosterone even if total testosterone remains normal. This can contribute to symptoms like reduced libido despite estrogen therapy.

What is the difference between total testosterone and free testosterone in women?

Total testosterone refers to all testosterone present in the bloodstream, while free testosterone is the fraction not bound tightly to proteins such as SHBG. Free testosterone is biologically active and available to tissues. High levels of SHBG can lower free testosterone levels even if total testosterone appears normal, which may impact symptoms related to sexual desire and vitality.

Is testosterone therapy effective for low sexual desire during menopause?

Yes. The strongest evidence supports the use of testosterone therapy for treating hypoactive sexual desire disorder (HSDD) in postmenopausal women—a persistent lack of sexual desire causing personal distress. Clinical trials have shown that testosterone can improve sexual desire, satisfaction, reduce distress, and help women feel more responsive and connected to their sexuality.

Can peri menopausal women benefit from testosterone therapy for sexual dysfunction?

While most guidelines focus on postmenopausal women, many clinicians evaluate peri menopausal women with distressing low sexual desire similarly when other factors are addressed and estrogen status is optimized. However, libido is complex and influenced by relationship context, mental health, medications, pain, sleep quality, and vaginal dryness. Testosterone is typically considered after addressing these factors.

Are there risks or concerns with using testosterone therapy for menopausal symptoms?

Yes. While some clinics may overpromise benefits of testosterone for issues like weight loss or mood without solid evidence, it’s important to approach therapy cautiously. Testosterone should be prescribed by knowledgeable clinicians who understand dosing and monitoring because inappropriate use can lead to side effects. Therapy should be individualized based on thorough evaluation rather than used as a catch-all solution.